126 related articles for article (PubMed ID: 37276927)
21. Nucleophosmin in leukemia: Consequences of anchor loss.
Brodská B; Šašinková M; Kuželová K
Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
[TBL] [Abstract][Full Text] [Related]
22. RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract][Full Text] [Related]
23. Nucleolar stress characterized by downregulation of nucleophosmin: a novel cause of neuronal degeneration.
Marquez-Lona EM; Tan Z; Schreiber SS
Biochem Biophys Res Commun; 2012 Jan; 417(1):514-20. PubMed ID: 22166220
[TBL] [Abstract][Full Text] [Related]
24. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
[TBL] [Abstract][Full Text] [Related]
25. [Nucleophosmin mutations in hematological malignancies - review].
Luo ZP; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):662-6. PubMed ID: 17605889
[TBL] [Abstract][Full Text] [Related]
26. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.
Li J; Zhang X; Sejas DP; Bagby GC; Pang Q
J Biol Chem; 2004 Oct; 279(40):41275-9. PubMed ID: 15310764
[TBL] [Abstract][Full Text] [Related]
28. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells.
Wojciechowski J; Horky M; Gueorguieva M; Węsierska-Gądek J
Int J Cancer; 2003 Sep; 106(4):486-495. PubMed ID: 12845642
[TBL] [Abstract][Full Text] [Related]
29. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.
Falini B; Bolli N; Shan J; Martelli MP; Liso A; Pucciarini A; Bigerna B; Pasqualucci L; Mannucci R; Rosati R; Gorello P; Diverio D; Roti G; Tiacci E; Cazzaniga G; Biondi A; Schnittger S; Haferlach T; Hiddemann W; Martelli MF; Gu W; Mecucci C; Nicoletti I
Blood; 2006 Jun; 107(11):4514-23. PubMed ID: 16455950
[TBL] [Abstract][Full Text] [Related]
30. Heterozygous
Sheikh TI; Harripaul R; Vasli N; Ghadami M; Santangelo SL; Ayub M; Sasanfar R; Vincent JB
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052391
[TBL] [Abstract][Full Text] [Related]
31. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
32. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
[TBL] [Abstract][Full Text] [Related]
33. RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells.
Jian Y; Gao Z; Sun J; Shen Q; Feng F; Jing Y; Yang C
Oncogene; 2009 Nov; 28(47):4201-11. PubMed ID: 19734942
[TBL] [Abstract][Full Text] [Related]
34. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
35. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
Di Fiore PP
J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
[TBL] [Abstract][Full Text] [Related]
36. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G
Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227
[TBL] [Abstract][Full Text] [Related]
37. BMH-21 inhibits viability and induces apoptosis by p53-dependent nucleolar stress responses in SKOV3 ovarian cancer cells.
Fu X; Xu L; Qi L; Tian H; Yi D; Yu Y; Liu S; Li S; Xu Y; Wang C
Oncol Rep; 2017 Aug; 38(2):859-865. PubMed ID: 28656213
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells.
Endo M; Nishioka T; Numazaki K; Hasegawa H; Takahashi T; Sugawara S; Tada H
Anticancer Res; 2022 Jun; 42(6):2931-2937. PubMed ID: 35641264
[TBL] [Abstract][Full Text] [Related]
39. Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA.
Zhao CY; Grinkevich VV; Nikulenkov F; Bao W; Selivanova G
Cell Cycle; 2010 May; 9(9):1847-55. PubMed ID: 20436301
[TBL] [Abstract][Full Text] [Related]
40. RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]